Page 2 - Sanket Koul

Medtech firms, hospitals back TMR amid medical device mark-up debate

Medtech manufacturers and private hospitals back trade margin rationalisation but seek a fact-based approach that accounts for category-specific costs and procurement structures

India's Ayush market could reach $213 billion by 2030: Primus Partners

Primus Partners says integrating Ayush into public health systems, insurance and primary care could help expand India's market to $213 billion by 2030 from $43 billion now

Accenture leases over 560,000 sq ft office space in Bengaluru for ₹269 cr

The five-year deal at Pritech Park SEZ includes renewal of an earlier lease for 441,000 sq ft and an additional 126,000 sq ft of office space

CDSCO flags indiscriminate use of painkillers, antibiotics over CKD risk

Drug regulator asks healthcare professionals and pharmacists to discourage indiscriminate use of NSAIDs and antibiotics, citing risks of kidney damage and CKD

Festive housing demand to stay healthy, but growth likely to moderate

Developers are becoming more calibrated in their launch strategies, while homebuyers are showing greater scrutiny around prices, payment terms and product quality

PB Health targets 150 hospitals, expansion into Tier-II, III cities

The venture aims to raise Rs 10,000 crore to build a network of 15,000-20,000 beds across more than 50 cities over the next five to six years

Gulshan Group, Ourika Estates form JV to invest ₹750 cr in UP projects

The platform has secured land parcels in Ghaziabad and Lucknow to develop about 1.5 million sq ft of built-up area across two premium residential projects

CDSCO forms expert panel to regulate AI use in drug discovery: DCGI

DCGI Rajeev Raghuvanshi says the panel includes AI experts and will discuss how AI used in drug discovery should be evaluated, approved and regulated

Centre asks states, UTs to clamp down on stem cell therapy for autism care

Health Ministry says stem cell therapy for autism must remain restricted to approved clinical trials, while unauthorised use could invite regulatory and disciplinary action.

Centre proposes CCTV surveillance in pharmacies to check unauthorised sales

Draft rules require CCTV surveillance for prescription drug sales at licensed premises and mandate that recordings be preserved for a minimum period of three months

Bigger homes gain favour as Indian buyers move higher up the price ladder

Anarock survey shows 3BHKs account for 48% of buyer preferences, while demand is increasingly shifting towards homes priced between Rs 90 lakh and Rs 1.5 crore

Healthcare industry divided over Maharashtra FDA's medical device pricing

Industry bodies back greater scrutiny of medical device pricing but differ on how gaps between hospital procurement costs and prices charged to patients should be assessed

Fortis moves SC against HC forensic audit order in company transactions

Fortis challenges forensic audit order in Supreme Court over alleged asset erosion during Daiichi Sankyo enforcement proceedings

Borderline case: Cosmetics from Pakistan breach Indian mkt, raise eyebrows

Drugs regulator says beauty creams from across the border are not registered, and contain excessive, toxic heavy metals

Centre plans ban on import, sale of two antibiotics for animal use in India

Draft notification seeks to prohibit carboxypenicillins and phosphonic acid derivatives in animals as India tightens antimicrobial-use rules to curb drug resistance.

Fortis moves SC against HC forensic audit order in company transactions

Fortis challenges forensic audit order in Supreme Court over alleged asset erosion during Daiichi Sankyo enforcement proceedings

Fortis moves SC against HC forensic audit order in company transactions

Fortis challenges forensic audit order in Supreme Court over alleged asset erosion during Daiichi Sankyo enforcement proceedings

Genpact leases 400K sq ft of office space in Gurugram for around ₹420 cr

The multi-year transaction will see Genpact occupy the entire Kings Canyon tower at ASF Insignia, an integrated 50-acre commercial IT campus in Gurugram

Domestic medtech manufacturers welcome Maha FDA's call for price review

AIMED backing comes after Maharashtra FDA Commissioner Tukaram Mundhe flagged mark-ups of up to 2,841% on medical devices and hospital consumables

Lupin to bet big on biosimilar sales in mid term, ramp capacity expansion

The company plans to soon start the funding process for its oncology spin-off, Kaveri Therapeutics, which houses two specialised oncology programmes